FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023198338> ?p ?o ?g. }

• W2023198338 endingPage "1891" @default.
• W2023198338 startingPage "1883" @default.
• W2023198338 abstract "Background— The presence of the ECG strain pattern of lateral ST depression and T-wave inversion at baseline has been associated with an increased risk of cardiovascular morbidity and mortality; however, the independent predictive value for cardiovascular outcomes of regression versus persistence versus development of new ECG strain during antihypertensive therapy is unclear. Methods and Results— ECG strain was evaluated at baseline and after 1 year of therapy in 7409 hypertensive patients in the LIFE study (Losartan Intervention For End-point reduction in hypertension) treated in a blinded manner with atenolol- or losartan-based regimens. During 3.8±0.8 years of follow-up after the year 1 ECG, cardiovascular death occurred in 236 patients (3.2%), myocardial infarction in 198 (2.7%), stroke in 313 (4.2%), the LIFE composite end point of these 3 events in 600 (8.1%), sudden death in 92 (1.2%), and death due to any cause in 486 (6.6%). Strain was absent on both baseline and year 1 ECGs in 6323 patients (85.3%), regressed from baseline to year 1 in 245 (3.3%), persisted on both ECGs in 549 (7.4%), and was absent at baseline but developed by year 1 in 292 patients (3.9%). Compared with absence of strain on both ECGs, development of new ECG strain was associated with 2.8- to 4.7-fold higher event rates; patients with regression or persistence of strain had intermediate event rates. In Cox multivariable analyses with adjustment for the known predictive value of in-treatment ECG left ventricular hypertrophy by Cornell product and Sokolow-Lyon voltage, in-treatment systolic and diastolic pressure, randomized treatment, and standard cardiovascular risk factors, development of new ECG strain was independently associated with increased risks of cardiovascular death (hazard ratio [HR] 2.42, 95% confidence interval [CI] 1.56 to 3.76), myocardial infarction (HR 1.95, 95% CI 1.11 to 3.44), stroke (HR 1.98, 95% CI 1.30 to 3.01), the LIFE composite end point (HR 2.05, 95% CI 1.51 to 2.78), sudden cardiac death (HR 2.19, 95% CI 1.06 to 4.53), and all-cause mortality (HR 1.92, 95% CI 1.37 to 2.69), whereas the risk associated with regression or persistence of strain was attenuated. Conclusions— Development of new ECG strain is associated with an increased risk of cardiovascular morbidity and mortality and of all-cause mortality in the setting of antihypertensive therapy and regression of ECG left ventricular hypertrophy." @default.
• W2023198338 created "2016-06-24" @default.
• W2023198338 creator A5018744150 @default.
• W2023198338 creator A5031475597 @default.
• W2023198338 creator A5036740466 @default.
• W2023198338 creator A5043802576 @default.
• W2023198338 creator A5044090184 @default.
• W2023198338 creator A5054747839 @default.
• W2023198338 creator A5058664894 @default.
• W2023198338 creator A5072871923 @default.
• W2023198338 creator A5087577272 @default.
• W2023198338 date "2009-04-14" @default.
• W2023198338 modified "2023-10-02" @default.
• W2023198338 title "Prognostic Value of Changes in the Electrocardiographic Strain Pattern During Antihypertensive Treatment" @default.
• W2023198338 cites W1964743455 @default.
• W2023198338 cites W1982910370 @default.
• W2023198338 cites W1992724018 @default.
• W2023198338 cites W2033671050 @default.
• W2023198338 cites W2046132290 @default.
• W2023198338 cites W2051995148 @default.
• W2023198338 cites W2069031723 @default.
• W2023198338 cites W2076642867 @default.
• W2023198338 cites W2090156708 @default.
• W2023198338 cites W2113738225 @default.
• W2023198338 cites W2115750582 @default.
• W2023198338 cites W2119841174 @default.
• W2023198338 cites W2129486470 @default.
• W2023198338 cites W2129605874 @default.
• W2023198338 cites W2133217116 @default.
• W2023198338 cites W2157870057 @default.
• W2023198338 cites W2166397210 @default.
• W2023198338 cites W2168692694 @default.
• W2023198338 cites W2171083313 @default.
• W2023198338 cites W2171580870 @default.
• W2023198338 cites W2180702045 @default.
• W2023198338 cites W2337042699 @default.
• W2023198338 doi "https://doi.org/10.1161/circulationaha.108.812313" @default.
• W2023198338 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19332468" @default.
• W2023198338 hasPublicationYear "2009" @default.
• W2023198338 type Work @default.
• W2023198338 sameAs 2023198338 @default.
• W2023198338 citedByCount "55" @default.
• W2023198338 countsByYear W20231983382012 @default.
• W2023198338 countsByYear W20231983382013 @default.
• W2023198338 countsByYear W20231983382014 @default.
• W2023198338 countsByYear W20231983382015 @default.
• W2023198338 countsByYear W20231983382016 @default.
• W2023198338 countsByYear W20231983382017 @default.
• W2023198338 countsByYear W20231983382018 @default.
• W2023198338 countsByYear W20231983382019 @default.
• W2023198338 countsByYear W20231983382020 @default.
• W2023198338 countsByYear W20231983382022 @default.
• W2023198338 countsByYear W20231983382023 @default.
• W2023198338 crossrefType "journal-article" @default.
• W2023198338 hasAuthorship W2023198338A5018744150 @default.
• W2023198338 hasAuthorship W2023198338A5031475597 @default.
• W2023198338 hasAuthorship W2023198338A5036740466 @default.
• W2023198338 hasAuthorship W2023198338A5043802576 @default.
• W2023198338 hasAuthorship W2023198338A5044090184 @default.
• W2023198338 hasAuthorship W2023198338A5054747839 @default.
• W2023198338 hasAuthorship W2023198338A5058664894 @default.
• W2023198338 hasAuthorship W2023198338A5072871923 @default.
• W2023198338 hasAuthorship W2023198338A5087577272 @default.
• W2023198338 hasBestOaLocation W20231983381 @default.
• W2023198338 hasConcept C126322002 @default.
• W2023198338 hasConcept C127413603 @default.
• W2023198338 hasConcept C164705383 @default.
• W2023198338 hasConcept C2776525901 @default.
• W2023198338 hasConcept C2780645631 @default.
• W2023198338 hasConcept C2993353509 @default.
• W2023198338 hasConcept C500558357 @default.
• W2023198338 hasConcept C50382708 @default.
• W2023198338 hasConcept C71924100 @default.
• W2023198338 hasConcept C78519656 @default.
• W2023198338 hasConcept C84393581 @default.
• W2023198338 hasConceptScore W2023198338C126322002 @default.
• W2023198338 hasConceptScore W2023198338C127413603 @default.
• W2023198338 hasConceptScore W2023198338C164705383 @default.
• W2023198338 hasConceptScore W2023198338C2776525901 @default.
• W2023198338 hasConceptScore W2023198338C2780645631 @default.
• W2023198338 hasConceptScore W2023198338C2993353509 @default.
• W2023198338 hasConceptScore W2023198338C500558357 @default.
• W2023198338 hasConceptScore W2023198338C50382708 @default.
• W2023198338 hasConceptScore W2023198338C71924100 @default.
• W2023198338 hasConceptScore W2023198338C78519656 @default.
• W2023198338 hasConceptScore W2023198338C84393581 @default.
• W2023198338 hasIssue "14" @default.
• W2023198338 hasLocation W20231983381 @default.
• W2023198338 hasLocation W20231983382 @default.
• W2023198338 hasOpenAccess W2023198338 @default.
• W2023198338 hasPrimaryLocation W20231983381 @default.
• W2023198338 hasRelatedWork W1563930237 @default.
• W2023198338 hasRelatedWork W1971681111 @default.
• W2023198338 hasRelatedWork W2008851126 @default.
• W2023198338 hasRelatedWork W2037817991 @default.
• W2023198338 hasRelatedWork W2049397185 @default.
• W2023198338 hasRelatedWork W2088634464 @default.
• W2023198338 hasRelatedWork W2129841526 @default.

• next